Academic Psychiatry
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Acad Psychiatry 31:32-39, February 2007
doi: 10.1176/appi.ap.31.1.32
© 2007 Academic Psychiatry
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
* Citation Map
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via Google Scholar
Google Scholar
* Articles by Geppert, C. M.A.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Geppert, C. M.A.
Related Collections
* Other Ethics Issues
* Education, Psychiatrists

Medical Education and the Pharmaceutical Industry: A Review of Ethical Guidelines and Their Implications for Psychiatric Training

Cynthia M.A. Geppert, M.D., Ph.D.

Received November 11, 2005; revised February 12, 2006; accepted March 23, 2006. Dr. Geppert is Assistant Professor, Department of Psychiatry, University of New Mexico, and Chief of Consultation Psychiatry and Ethics, New Mexico Veterans Affairs Health Care System, Albuquerque, New Mexico. Address correspondence to Dr. Geppert, 1501 San Pedro Drive Southeast, Albuquerque, NM 87108; ethicdoc{at}comcast.net (e-mail).

OBJECTIVE: This article reviews and summarizes eight ethical guidelines of major professional organizations regarding the pharmaceutical industry’s role in the psychiatric education of trainees. METHOD: The author conducted a literature review of research and guidelines pertaining to the pharmaceutical industry’s relationship to trainees, with special attention to ethical implications.RESULTS: A spectrum of ethical acceptability is represented in the various guidelines. The greatest disagreement exists regarding the appropriateness of gift-giving and hospitality. The greatest degree of consensus exists regarding the provision of and criteria for scholarships to trainees. Policies regarding the use of samples and the industry’s influence on graduate medical education were less well developed compared with other areas. CONCLUSIONS: A review of guidelines can serve as a basis for dialogue, curricula development, and further research on the ethics of pharmaceutical company interactions with trainees in academic psychiatry.




This article has been cited by other articles:


Home page
FocusHome page
Bibliography for Ethics, Professionalism, and End of Life Care
Focus, January 1, 2007; 5(4): 417 - 419.
[Full Text] [PDF]




Get information about faster international access.

Privacy Policy

Copyright © 2007 Academic Psychiatry. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Association of Chairs of Departments of Psychiatry American Association of Directors of Psychiatric Residency Training Association of Directors of Medical Student Education in Psychiatry Association for Academic Psychiatry
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org